Cryopreserved MMUD BM With PTCy for Hematologic Malignancies
Status:
Not yet recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
Multicenter single arm study to assess the safety and efficacy of allogeneic transplantation
using cryopreserved bone marrow from deceased MMUD and PTCy, sirolimus and MMF for GVHD
prophylaxis.
Phase:
Phase 1
Details
Lead Sponsor:
Ossium Health, Inc.
Collaborator:
Center for International Blood and Marrow Transplant Research